Rousselot Biomedical presentation highlights from the 31st conference of the European Society of Biomaterials conference 2021’

Session discussion highlights include:

• The unique properties of Gelatin for 3D bioprinting: The use of gelatin to stably incorporate nanoparticles into printable bio-inks.
• The biocompatibility of Gelatin for use in regenerative medicines: The ability of gelatin to steer the behavior of immune cells such as macrophages towards a regenerative phenotype, or to endow bio-printed cartilage-like tissue constructs with spatially controlled mechanical properties.
• The advantages of gelatin for use as a bio-adhesive: The chemical modification of gelatin to act as hemostatic bio-adhesive or implantable energy storage devices.

Our expert Dr Jeff Daelman shares insights from our latest research into how purified and consistently produced gelatin can reduce experimental bias and allow for efficient clinical translation.

X-Pure® is intensely purified, specifically for biomedical applications

Rousselot Biomedical has designed X-Pure® – our purest ever range of gelatins, with some of the lowest endotoxins (<10 endotoxin units (EU)/g) available on the market.

Endotoxin levels in traditionally manufactured gelatin and collagen are typically >100 times higher. Our patented process removes process impurities, as well as soluble impurities such as endotoxins (LPS) and methacrylic acid (MA), resulting in consistent ultra-low impurity levels.

Rousselot is the global leader in collagen and gelatin solutions and we are proud to offer a customizable, GMP-certified and FDA/EMA-compliant biomaterial formulation.